晟斯生物是多款新药产品处于临床阶段，立足中国、面向全球的创新生物药公司。
公司的创新发展策略，以临床需求为依据，以具备临床优势为导向，以血液系统疾病为起点，以罕见病药物开发为突破口，旨在开发不同临床适应症上具有高度差异化特质的生物大分子创新药物。
公司力争高安全性、高有效性、高成功率并举，努力成为全球生物制药领域持续创新者，造福于全世界相关患者群体。
公司集研发、开发、生产和商业化于一体。目前，公司自主研发的长效重组凝血八因子产品已进入临床三期研究阶段，超长效重组凝血八因子产品申报临床。公司同时加速推动以肿瘤和代谢疾病为代表的临床需求热点相关的，多元化新型疗法药物管线。
Company Details
- Employees
- 8
- Founded
- -
- Address
- 亦庄经济技术开发区荣昌东街7号院隆盛工业园, B幢5号楼5层东,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.gensciences.cn
- Keywords
- Shanghai.
- HQ
- 北京市
Gensciences Questions
Gensciences's website is http://www.gensciences.cn
Gensciences has
8 employees.
View email and phone details for 8
employees at Gensciences.
Gensciences's industry is
Pharmaceutical Manufacturing
Gensciences's top competitors are
Pptclass,
Taeltech (橙感),
Qingdao Singho Industrial Company Ltd.,
Mybiogate 美柏医健,
Beijing Tigsun Diagnostics Co., Ltd.,
Menci International,
Transgreen Capital,
Sciclone Pharmaceuticals,
Forewarned Inc,
Hengrui Pharma.
Gensciences's categories are Pharmaceutical Manufacturing
Gensciences's founding year is 2019
